- Home
- » Tags
- » Drotrecogin alfa
Top View
- Venous Thromboembolism, Coagulation and Cancer Van Doormaal, F.F
- New Therapeutic Options for Patients with Sepsis and Disseminated Intravascular Coagulation
- Systemic Glucocorticoids in the Treatment of COVID-19 and Risks of Adverse Outcomes in COVID-19 Patients in the Primary and Secondary Care Setting
- 140-239.9 Organ Failure
- Xigris, INN-Drotrecogin Alfa (Activated)
- Drotrecogin Alfa (Activated)
- ICU Resident's Guide
- Deuterated Derivatives of Ticagrelor for Medical Use
- Management of Sepsis
- ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
- Pharmacological Agents Targeting Thromboinflammation in COVID-19
- Update on Antiplatelet Therapy in Cardiovascular Disease
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Drotrecogin Alfa (Activated): a Novel Therapeutic Strategy for Severe Sepsis S M Pastores
- Adjuvent and New Therapeutic Interventions in Septic Shock ?
- Drotrecogin Alfa (Activated), Xigris, Label
- WHO Drug Information Vol
- Lilly and Investor Group Form New Critical Care Company Biocritica, Sign Xigris License Agreement
- WHO Drug Information Vol 19, No
- ANTICOAGULANT, THROMBOLYTIC, and ANTI-PLATELET DRUGS
- Research Proposal - the TC4 Trial Brophy
- Xigris, INN-Drotrecogin Alfa
- Drotrecogin Alfa (Activated) in Severe Sepsis: a Systematic Review of Observational Studies (Update of Report 29)
- Relative Antithrombotic and Antihemostatic Effects of Protein C Activator Versus Low-Molecular-Weight Heparin in Primates
- Inflammation and Coagulation: Implications for the Septic Patient
- How Safe and Innovative Are First-In-Class Drugs Approved by Health Canada: a Cohort Study
- New Zealanders' Access to Licensed and Subsidised Medicines Compared with a Nationwide Single Payer System In
- Restrictions in Use and Availability of Pharmaceuticals 2010 - 2018
- Resolution Ap (2000) 1
- Use of Recombinant Human Activated Protein C in Treatment of Severe
- Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
- Drotrecogin Alfa - Drugbank
- Xigris Drotrecogin Alfa
- Methodik Der ATC-Klassifikation Und DDD-Festlegung Für Den Deutschen